10.1111/epi.13026 104 RowleyS.LiangL.-P.FultonR.ShimizuT.DayB.PatelM
Dual-action GLP-1 + GIP Physician-prescribed Physician-prescribed compounded tirzepatide with dual GLP-1 and GIP hormone action
Product details Net content: 80 mg per vial Format: Lyophilized material Container: 3 mL glass vial Lot/batch: Recorded on every vial label Intended use Non-clinical laboratory research Analytical reference and assay development within institutional programs Use only in accordance with institutional SOPs and applicable regulatory requirements Not for human or animal consumption Not for clinical, therapeutic, diagnostic, cosmetic, or personal use Certificate of Analysis (COA) For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for KLOW Canada 80mg
Trulicity Product Information (SmPC)
These are consistent across every pen because theyre part of the approved formulation
Liraglutide is a human GLP-1 analog (3,751.2 Da) with 97% homology to native GLP-1, designed to bind to albumin via a fatty acid and a spacer covalently attached to the peptide backbone [20]
